Тherapy with the angiotensin-converting enzyme inhibitor zofenopril as a new direction in the treatment of primary glaucoma
The Functioning of Healthcare in EU Countries and Ukraine in Maintaining Sustainable Development (March 19–20, 2025. Riga, the Republic of Latvia) : International scientific conference. Riga, Latvia : Baltija Publishing, 2025. 84 pages.
Authors
- T. Siroshtanenko (ORCID: https://orcid.org/0009-0009-9280-7453)
- S. G. Kolomiichuk (ORCID: https://orcid.org/0009-0005-1372-3616)
- I. N. Mikheytseva
Institutions
- Filatov Institute of Eye Diseases and Tissue Therapy of the National Academy of Medical Sciences of Ukraine (UA)
Publication Details
- Published
- 2025-01-01
- DOI
- https://doi.org/10.30525/978-9934-26-549-5-11
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00